MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Nocturnal behavior of people with Parkinson’s disease

C. Duval, A. Karelis, J. Daneault (Montreal, Canada)

Meeting: 2023 International Congress

Abstract Number: 438

Keywords: Motor control, Parkinson’s, Sleep disorders. See also Restless legs syndrome: Clinical features

Category: Parkinson's Disease: Non-Motor Symptoms

Objective: Compare the nocturnal energy expenditure (kcal) and activity behavior of people with PD using a real-time wearable sensor, and determine whether these outcomes differed from people without PD.

Background: Studies have reported that between 49 and 66% of people with PD experience sleep disturbances such as lower sleep duration time and a higher number of awakenings, increased muscle tone and activity, and restless legs syndrome. Due to the sleep disturbances and sleep-related motor abnormalities, it is possible that the energy expenditure during sleep may be different for these people with PD compared to healthy controls.

Method: Fifty people properly diagnosed with PD (29 men) and 50 healthy control participants matched one for one for age and sex were recruited. Sleep duration, time spent lying down, total energy expenditure as well as the intensity and variability of energy expenditure were evaluated for 14 consecutive days using the portable mini SenseWear armband (Bodymedia, Pittsburgh, PA, USA). Using the minute-by-minute data output, we also calculated a variability score based on the energy expenditure data (A.U.) to detect subtle variations in energy expenditure. Bioelectrical impedance was measured using the Inbody 230 multifrequency analyser (Biospace, CA, USA). Standing height (± 0.1 cm) was measured with a measuring tape. Body mass index [BMI = Body weight (kg)/Height (m2)] was then calculated.

Results: Over the testing period, we found that total energy expenditure was significantly higher in people with PD compared to the control participants (P < 0.05), whereas the amount of time lying down was significantly lower for people with PD (P < 0.05). Similar results were found for both men and women with PD when compared to healthy controls, suggesting that the findings of the present study are independent of sex. We did not observe any differences between groups in sleep duration as measured by the armband. Age, height, fat mass was also similar between groups suggesting that the findings of the present study are independent of sex.

Conclusion: Energy expenditure at night was higher and lying down time was lower in people with PD, suggesting greater movement and/or muscle activity at night. These findings should be considered preliminary, but they may hopefully stimulate interest for additional research on the characterization of nocturnal behavior profiles of people with PD.

To cite this abstract in AMA style:

C. Duval, A. Karelis, J. Daneault. Nocturnal behavior of people with Parkinson’s disease [abstract]. Mov Disord. 2023; 38 (suppl 1). https://www.mdsabstracts.org/abstract/nocturnal-behavior-of-people-with-parkinsons-disease/. Accessed May 23, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2023 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/nocturnal-behavior-of-people-with-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley